Prediction of atrial fibrillation development and progression: Current perspectives

doi:10.4330/wjc.v8.i3.267

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12640)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

1045

WORD

302

HTML

7097

Tables (1-1)

469

Sum=8913

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1473

Download

2254

Sum=3727

Mar 26, 2016 (publication date) through Oct 23, 2025

Times Cited of This Article

Times Cited (46)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Cardiol. Mar 26, 2016; 8(3): 267-276
Published online Mar 26, 2016. doi: 10.4330/wjc.v8.i3.267

Table 1 Conventional and novel risk factors for atrial fibrillation development and progression

Well-established risk factors

AF (AF begets AF)

Valvular heart disease

Hypertension

Coronary artery disease

Heart failure

Left atrial dilatation

Diabetes mellitus

Advancing age

Sex (male)

Congenital heart disease

Acute pericarditis

Hyperthyroidism

Alcohol consumption

Less-established risk factors

Obstructive pulmonary disease

Obstructive sleep apnea syndrome

Obesity

Left ventricular diastolic dysfunction

Atrial conduction delay (PR interval prolongation)

Genetic factors

Ethnicity

Emerging risk factors

Chronic kidney disease

Fibrosis

Inflammation

Elevated natriuretic peptides

AF: Atrial fibrillation.

Full Size Table

Citation: Vlachos K, Letsas KP, Korantzopoulos P, Liu T, Georgopoulos S, Bakalakos A, Karamichalakis N, Xydonas S, Efremidis M, Sideris A. Prediction of atrial fibrillation development and progression: Current perspectives. World J Cardiol 2016; 8(3): 267-276
URL: https://www.wjgnet.com/1949-8462/full/v8/i3/267.htm
DOI: https://dx.doi.org/10.4330/wjc.v8.i3.267